JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Čes-slov Pediat 2023, 78(2):110-121 | DOI: 10.55095/CSPediatrie2023/016

Myocarditis and cardiomyopathyKapitoly k atestaci z pediatrie

Jan Pavlíček1, Kristina Rücklová2, Jan David3
1 Klinika dětského lékařství, Lékařská fakulta Ostravské univerzity a Fakultní nemocnice Ostrava
2 Klinika dětí a dorostu, 3. lékařská fakulta a Fakultní nemocnice Královské Vinohrady, Praha
3 Pediatrická klinika, 2. lékařská fakulta a Fakultní nemocnice v Motole, Praha

The review article summarizes the most important information about myocarditis and cardiomyopathies in children. It focuses on their aetiology, clinical manifestations, diagnosis and treatment and may be used as a background material for preparation for the qualification exam in paediatrics.

Keywords: myocarditis, cardiomyopathy, heart failure, paediatrics

Published: March 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pavlíček J, Rücklová K, David J. Myocarditis and cardiomyopathy. Ces-slov Pediat. 2023;78(2):110-121. doi: 10.55095/CSPediatrie2023/016.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arola A, Pikkarainen E, Sipilä JO, et al. Occurrence and features of childhood myocarditis: a nationwide study in Finland. J Am Heart Assoc 2017; 6(11): e005306. Go to original source... Go to PubMed...
    2. Law YM, Lal AK, Chen S, et al. Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association. Circulation 2021; 144(6): e123-e135. Go to original source... Go to PubMed...
    3. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017; 135(17): e927-e999. Go to original source... Go to PubMed...
    4. de Loizaga SR, Beaton AZ. Rheumatic fever and rheumatic heart disease in the United States. Pediatr Ann 2021; 50(3): e98-e104. Go to original source... Go to PubMed...
    5. Aeschlimann FA, Misra N, Hussein T, et al. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascularmagnetic resonance based multicenter international study-the CARDOVID registry. J Cardiovasc Magn Reson 2021; 23(1): 140. Go to original source... Go to PubMed...
    6. Arbustini E, Narula N, Giuliani L, et al. Genetic basis of myocarditis: myth or reality? Myocarditis 2020; 45-89. Go to original source...
    7. Bracamonte-Baran W, Čiháková D. Cardiac autoimmunity: myocarditis. Adv Exp Med Biol 2017; 1003: 187-221. Go to original source...
    8. Ammirati E, Veronese G, Bottiroli M, et al. Update on acute myocarditis. Trends Cardiovasc Med 2021; 31(6): 370-379. Go to original source...
    9. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009; 53: 1475-1487. Go to original source...
    10. Meune C, Spaulding C, Mahé I, et al. Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug Saf 2003; 26: 975-981. Go to original source...
    11. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003; 348: 1647-1655. Go to original source...
    12. Lipshultz SE, Law YM, Asante-Korang A, et al.; American Heart Association Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Council on Genomic and Precision Medicine. Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association. Circulation 2019; 140(1): e9-e68. Go to original source... Go to PubMed...
    13. Tomašov P. Genetika kardiomyopatií. Cor Vasa 2010; 52: 399-402. Go to original source...
    14. Lee TM, Hsu DT, Kantor P, et al. Pediatric cardiomyopathies. Circ Res 2017; 121: 855-873. Go to original source...
    15. Braunwald E. Cardiomyopathies: an overview. Circ Res 2017; 121: 711-721 Go to original source...
    16. Towbin JA, Jefferies JL. Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism. Circ Res 2017; 121(7): 838-854. Go to original source...
    17. Feingold B, Mahle WT, Auerbach S, et al.; American Heart Association Pediatric Heart Failure Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; Council on Functional Genomics and Translational Biology; and Stroke Council. Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the American Heart Association. Circulation 2017; 136(13): e200-e231. Go to PubMed...
    18. Alvarez JA, Orav EJ, Wilkinson JD, et al.; Pediatric Cardiomyopathy Registry Investigators. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the Pediatric Cardiomyopathy Registry. Circulation 2011; 124: 814-823. Go to original source... Go to PubMed...
    19. Monda E, Rubino M, Lioncino M, et al. Hypertrophic cardiomyopathy in children: pathophysiology, diagnosis, and treatment of non-sarcomeric causes. Front Pediatr 2021; 9: 94. Go to original source...
    20. Moak JP, Kaski JP. Hypertrophic cardiomyopathy in children. Heart 2012; 98(14: 1044-1054. Go to original source...
    21. Ziółkowska L, Turska-Kmieć A, Petryka J, Kawalec W. Predictors of long-term outcome in children with hypertrophic cardiomyopathy. Pediatr Cardiol 2016; 37(3): 448-458. Go to original source...
    22. Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 2007; 115: 773-781. Go to original source... Go to PubMed...
    23. Miron A, Lafreniere-Roula M, Steve Fan CP, et al. A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy. Circulation 2020; 142(3): 217-229. Go to original source... Go to PubMed...
    24. Norrish G, Ding T, Field E, et al. Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids). JAMA Cardiol. 2019; 4(9): 918-927. Go to original source...
    25. Ditaranto R, Caponetti AG, Ferrara, V, et al. Pediatric restrictive cardiomyopathies. Front Pediatr 2021; 9: 745365. Go to original source... Go to PubMed...
    26. Anderson HN, Cetta F, Driscoll DJ, et al. Idiopathic restrictive cardiomyopathy in children and young adults. Am J Cardiol 2018; 121(10): 1266-1270. Go to original source...
    27. Chen L, Song J, Chen X, et al. A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression. Eur Heart J 2019; 40(21): 1690-1703. Go to original source...
    28. Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm 2019; 16(11): e301-e372. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content